Hims(US:HIMS) Prnewswire·2025-07-25 12:45Core Points - A class action securities lawsuit has been filed against Hims & Hers Health, Inc. for alleged securities fraud occurring between April 29, 2025, and June 23, 2025 [1][2] - The lawsuit claims that Hims was involved in deceptive practices related to the promotion and sale of illegitimate versions of Wegovy®, which jeopardized patient safety and risked the termination of its collaboration with Novo Nordisk [2] - Investors affected by the alleged fraud have until August 25, 2025, to request to be appointed as lead plaintiff, with no out-of-pocket costs for class members to participate [3] Company Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4]